LOBENZARIT disodtulIl (CCA) is a novel immunomodulatory drug useful in the treatment of chronic inflammations. Its principal mechanism of action seems to be through enhancing the T suppressor/ T helper lymphocyte ratio. However, the molecular basis for these actions remains unclear. In this study it was found that CCA inhibits the production of guanosine 3',5'-cyclic monophosphate almost completely when present in concentrations of lmM. Further results demonstrated that such inhibition could also be explained by interference in constitutive nitric oxide generation. In addition to previous f'mdings, more insight into the molecular mechanism of action of CCA is provided.
Introduction N-(2-carboxyl phenyl)-4-chloro anthranilic acid disodium salt (CCA), known as lobenzarit disodium, is a novel immunomodulatory drug useless in the treatment of acute inflammation but experimentally very useful in the treatment of chronic inflammatory auto-immune diseases such as rheumatoid arthritis 2 and diabetes. 3 Its mechanism of action may be related to its capacity to enhance the T suppressor/T helper lymphocyte ratio. 4 However, from a molecular point of view the nature of the effect remains unclear.
CCA is a radical scavenging molecule derived from anthranilic acid 5 
Replicates n-6 n 5 n 5 n 3 n 3 n 6 *p< 0.05 and 'p < 0.01 when compared with the production of cGMP in the control group (+CCA 0mM). To assess the real amount of cGMP generated in 10 min, the level of cGMP present at time zero (background), was for each case subtracted. Percentages of inhibition are calculated by comparison with the total cGMP generated after 10 min in the absence of CCA. L-NMMA was used as an additional control because of the involvement of the cNOS metabolic pathway in the generation of cGMP. 
Discussion
Considering that the inhibition of the guanylate cyclase system by CCA proved to be sufficient to reduce cGMP levels by 50% even at 0.01 mM, this action will probably have biological significance in terms of its molecular pharmacodynamics when in vivo conditions are considered.
Curiously, in our system L-NMMA (0.05mM) does not abrogate the production of cGMP to the same extent as is observed for NO generation. This could be either because there is another NO-independent mechanism for guanylate cyclase stimulation 21 
